period where I had 10 new melanomas, which I think as a solo practitioner is extraordinary,” Palm said. “Eight out of these 10 I found, the patient was unaware of them.”
Nearly 20 Americans die from melanoma every day, according to the American Academy of Dermatology.
Langill wound up in a clinical trial for Keytruda (pembrolizumab), a new immunology drug that turns the body’s immune system against cancer cells.
“What they know about melanoma, once it’s migrated in the body it’s very aggressive even in microscopic quantities,” Langill said. “Chemo is not super-effective on melanoma, so they suggested a clinical trial at the University of California, San Diego Medical Center.”
Langill is now cancer-free, but she dreads every
